VETTER PHARMA INTERNATIONAL GmbH
Eywiesenstr. 5
88212 Ravensburg, Germany
T: +49-(0)751-3700-0
F: +49-(0)751-3700-4000
E: info@vetter-pharma.com
W: www.vetter-pharma.com

Vetter Pharma International USA Inc.
10 W. Algonquin Road
Des Plaines, IL 60016
T: (847) 581-6888
F: (847) 581-6880
E: infoUS@vetter-pharma.com
LinkedIn: https://www.linkedin.com/company/vetter-pharma/
YouTube: https://www.youtube.com/channel/UCANcZrENXdzIusvN9Rapgqw 

YOUR PARTNER IN ASEPTIC FILLING AND PACKAGING

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges, and vials. Vetter holds numerous patents and has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons, and vaccines. More than 80% of Vetter’s active projects are biologics.

Collaborating with biotechnology and pharmaceutical companies both large and small, Vetter supports products from preclinical development through global market supply. Through its US and European facilities, Vetter Development Service provides state-of-the-art support for early stage products, with transfer at Phase III to Vetter Commercial Manufacturing for large-scale production.
We offer state-of-the-art technology and innovative processes to promote product quality and maximize API yield.

VETTER AT A GLANCE

– Headquarters in Ravensburg, Germany

– Additional clinical development facility in Chicago, US, and Rankweil, Austria

– Sales offices for Asia Pacific in Singapore, Japan, South Korea, and China

– Approximately 5,700 employees

– Worldwide specialist in the aseptic production of prefilled drug delivery systems

– Global experience and expertise with regulatory authorities including FDA, EMA, PMDA (Japan), and RP (Germany)

– Lyophilization (freeze-drying) & siliconization specialist

 

SPECIALIZED EXPERTISE THAT GIVES YOU AN INSIDE EDGE

Tap into the knowledge of specialists with decades of experience identifying and solving difficult challenges. From technical obstacles such as siliconization and lyophilization to strategic issues such as life cycle planning, Vetter’s integrated team approach brings together the right experts for your compound’s precise requirements.

This kind of expertise is at the heart of what makes a CDMO a valuable partner for your injectable. When you consider all the criteria your outsourcing partner should meet – experience with a broad range of injectables, deep scientific and manufacturing resources, financial stability, and even a commonly shared vision – a partner whose expertise goes above and beyond clearly stands out.

Contact us

Visit www.vetter-pharma.com or contact us at info@vetter-pharma.com, infoUS@vetter-pharma.com, or infoAsiaPacific@vetter-pharma.com for more information.